Insider Analysis From Sidley Austin LLP: China's New Drug and Device Measures - Real Politics
This article was originally published in PharmAsia News
Executive Summary
By: Chen Yang, Sidley Austin LLP, Beijing & Scott Bass, Sidley Austin LLP, Washington, D.C